Evaxion Presents New Preclinical Data for AI-Designed CMV Vaccine Program EVX-V1
New preclinical findings show AI-discovered T-cell epitopes may improve control of CMV infection.
New preclinical findings show AI-discovered T-cell epitopes may improve control of CMV infection.
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
Research in children treated for the brain tumor ependymoma finds severe hearing loss is associated with worse intellectual ability and highlights the need for hearing interventions.
Researchers have identified what causes “specific musical anhedonia”—a condition where people feel no pleasure from music.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
The therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
Researchers have adapted the low-cost OCT imaging method developed for ophthalmology and used it to visualize tiny structures in the human inner ear.